ClinicalTrials.Veeva

Menu

Real-world Evaluation of JBA GlucoTrojan With Reducose® on Glycemic Response

T

Tastermonial Inc

Status

Completed

Conditions

Food Habits

Treatments

Dietary Supplement: Glucotrojan

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT06509204
1351713

Details and patient eligibility

About

The project is focused on evaluating the real-world efficacy of JBA GlucoTrojan, a powdered supplement sachet containing Reducose, a natural water extract of White Mulberry Leaf, which has been scientifically proven to reduce the absorption of sugars and carbs by up to 40%. The study aims to compare the effect of consuming GlucoTrojan with a meal (Test Meal) vs. having the meal alone (control) on the blood sugar response of 50 healthy adults, pre-diabetes, or non-insulin dependent diabetes, over a period of 14 days. It is expected that GlucoTrojan will reduce the incremental area under the curve and the peak for plasma glucose concentration over 120 minutes in normoglycemic adults when compared to the response to a control meal.

Enrollment

30 patients

Sex

All

Ages

21 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Consent to study protocol
  • BMI: 18.5 to 29.9 kg/m2
  • 21 to 75 years old

Exclusion criteria

  • Physician-diagnosed T1D and insulin-dependent T2D
  • Taking medications that modulate blood glucose response or control blood pressure other than Metformin
  • An underlying health condition that warrants non-participation
  • Individuals who are pregnant
  • Any other dietary restrictions that prevent them from consuming study foods
  • Unable to follow remote guidance via the Internet or smartphone
  • Unable to follow controlled diet instructions
  • Unable to use a CGM (Continuous Glucose Monitoring Devices)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Consumer
Experimental group
Description:
AQP Pharmaceuticals, Inc. ("Company") developed a powdered supplement sachet that can be added to meals targeting consumers who follow carbohydrate-heavy Asian diets. The product is formulated with the patented ingredient, "Reducose®", a natural water extract of novel White Mulberry Leaf that has been scientifically proven to reduce the absorption of sugars and other carbs by up to 40%. The effects have been confirmed previously via Randomized, Double-Blind, Controlled Trials. The Company is looking to conduct a real-world study of blood glucose responses to JBA GlucoTrojan (see specifications here) with a 5% concentration of Reducose®. The study will observe the real-world efficacy of GlucoTrojan when taken with high carbohydrate meals.
Treatment:
Dietary Supplement: Glucotrojan

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems